TransEnterix (TRXC) : Traders are bullish on TransEnterix (TRXC) as it has outperformed the S&P 500 by a wide margin of 22.24% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 9.56%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 9.74% in the last 1 week, and is up 21.58% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 12.33% and the 50-Day Moving Average is 17.33%.The 200 Day SMA reached 28.46%
TransEnterix (NYSEMKT:TRXC): After opening at $1.6, the stock dipped to an intraday low of $1.59 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $1.7 and the buying power remained strong till the end. The stock closed at $1.69 for the day, a gain of 4.32% for the day session. The total traded volume was 596,948. The stocks close on the previous trading day was $1.69.
TransEnterix (TRXC) : 3 Wall Street analysts covering TransEnterix (TRXC) believe that the average level the stock could reach for the short term is $3.58. The maximum price target given is $4 and the minimum target for short term is around $3, hence the standard deviation is calculated at $0.52.
TransEnterix, Inc. is a medical device company focused on the development and commercialization of a robotic assisted surgical system called the SurgiBot System (the SurgiBot System). The Companys SurgiBot System is designed to utilize flexible instruments through articulating channels controlled directly by the surgeon with robotic assistance while the surgeon remains patientside within the sterile field. It has commercialized the SPIDER Surgical System, (the SPIDER System) a manual laparoscopic system in the United States, Europe and the Middle East. The SPIDER System utilizes flexible instruments and articulating channels that are controlled directly by the surgeon, allowing for multiple instruments to be introduced through a single site. It also offers Flex Ligating Shears (FLS) which is an energy device used with the existing SPIDER Surgical System. The FLS device is designed to deliver controlled energy to ligate and divide tissue.